Thrombotic thrombocytopenic purpura associated with ticlopidine therapy

Journal of the American Society of Nephrology

Volumn 8, Issue 4, 1997, Pages 689-694

  Leavey, Sean F ^a,b   Weinberg, Joel ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b Box 0676   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MITOMYCIN C; QUININE; TICLOPIDINE;

ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0030667295     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Flores-Runk P, Raasch RH: Ticlopidine and antiplatelet therapy. Ann Pharmacother 27: 1090-1098, 1993
2. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients: Ticlopidine Aspirin Stroke Study Group. N Engl J Med 321: 501-507, 1989
3. Lakkis FG, Campbell OC, Badr KF: Microvascular diseases of the kidney. In: The Kidney, 5th Ed., edited by Brenner BM, Philadelphia, Saunders, 1996, pp. 1712-1717
4. Page Y, Tardy B, Zeni F, Comtet C, Terrana R, Bertrand JC: Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet 337: 774-776, 1991
5. Capra R, Marciano N, Fieni F, Capucci M, Ferremi P, Orlandini A: Cerebral hemorrhage and thrombotic thrombocytopenic purpura during ticlopidine treatment: Case report. Acta Neurol Belg 92: 83-87, 1992
6. Ellie E, Durrieu C, Besse P, Julien J, Gbipki-Benissan G: Thrombotic thrombocytopenic purpura associated with ticlopidine. Stroke 23: 922-923, 1992
7. Falezza G, Girelli D, Olivieri O, Gandini G, Corrocher R, De Sandre G: Thrombotic thrombocytopenic purpura developed during ticlopidine therapy. [Letter]. Haematologica 77: 525, 1992
8. Kovacs MJ, Soong PY, Chin-Yee IH: Thrombotic thrombocytopenic purpura associated with ticlopidine. Ann Pharmacother 27: 1060-1061, 1993
9. Centurioni R, Candela M, Leoni P, Minnucci ML, Danieli G: Is ticlopidine really responsible for thrombotic thrombocytopenic purpura (TTP)? [Letter; Comment.] Haematologica 78: 196-197, 1993
10. Viannelli N, Catani L, Belmonte MM, Sermasi G, Cascione ML, Gianni L, Zucchelli P, Bandini, G, Belardinelli A, Gugliotta L: Ticlopidine in the treatment of thrombotic thrombocytopenic purpura: Report of two cases. Haematologica 75: 274-277, 1990
11. Di Minno G, Cerbone AM, Mattioli PL, Turco S, Iovine C, Mancini M: Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 75: 328-338, 1985
12. Feliste R, Delebassee D, Simon MF, Chap H, Defreyn G, Vallee E, Douste-Blazy L, Maffrand JP: Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thromb Res 48: 403-415, 1987
13. Claas FH, de Fraiture WH, Meyboom RH: Thrombocytopenia due to antibodies induced by ticlopidine. Nouv Rev Fr Hematol 26: 323-324, 1984
14. Piovella F, Ricetti MM, Almasio P, Samaden A, Semino G, Ascari E: The effect of ticlopidine on human endothelial cells in culture. Thromb Res 33: 323-332, 1984
15. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS, Neefe JR: Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry. J Clin Oncol 7: 781-789, 1989
16. Snyder HW, Jr., Mittelman A, Oral A, Messerschmidt G, Henry DH, Korec S, Bertram JH, Guthrie TH Jr, Ciravarella D, Wuest D, Perkins W, Balint W, Balint JP Jr, Cochran SK, Puegeot RL, Jones FR: Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer 71: 1882-1892, 1993
17. Cattell V: Mitomycin-induced hemolytic uremic kidneys: An experimental model in the rat. Am J Pathol 121: 88-95, 1985
18. Hoorn CM, Wagner JG, Petry TW, Roth RA: Toxicity of mitomycin C toward cultured pulmonary artery endothelium. Toxicol Appl Pharmacol 130: 87-94, 1995
19. Duperray A, Tranqui L, Alix JL, Cordonnier D: Effect of mitomycin C on prostacyclin synthesis by human endothelial cells. Biochem Pharmacol 37: 4753-4757, 1988
20. Remuzzi G, Bertani T: Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 13: 261-272, 1989
21. Pettitt AR, Clark RE: Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 14: 495-504, 1994
22. Agarwal A, Mauer SM, Matas AJ, Nath KA: Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: Current concepts and management. J Am Soc Nephrol 6: 1160-1169, 1995
23. Hochstetler LA, Flanigan MJ, Lager DJ: Transplant-associated thrombotic microangiopathy: The role of IgG administration as initial therapy. Am J Kidney Dis 23: 444-450, 1994
24. Huang LQ, Whitworth JA, Chesterman CN: Effects of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cells. Blood Coagul Fibrinolysis 6: 438-445, 1995
25. Phair PG, Powell HR, McCredie DA: Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients. Transplant Proc 26: 3722-3726, 1994
26. Gottschall JL, Neahring B, McFarland JG, Wu GG, Weitekamp LA, Aster RH: Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol 47: 283-289, 1994